(Q52046063)

20 April 2018

title

Effect of alaptide, its analogues and oxiracetam on memory for an elevated plus-maze in mice. (English)

1 reference

20 April 2018

1 reference

2

1 reference

20 April 2018

author name string

Z Hlinák

series ordinal

1

1 reference

20 April 2018

E Kasafírek

series ordinal

3

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 October 1996

1 reference

20 April 2018

European Journal of Pharmacology

published in

1 reference

20 April 2018

volume

314

1 reference

20 April 2018

issue

1-2

1 reference

20 April 2018

page(s)

1-7

1 reference

20 April 2018

Vasopressin and behavior: from memory to olfaction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900485-2

Modulation of social memory in male rats by neurohypophyseal peptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900485-2

Commentary: behaviourally active ACTH analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900485-2

Central target for the behavioural effects of vasopressin neuropeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900485-2

Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900485-2

Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900485-2

The use of a plus-maze to measure anxiety in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900485-2

Trends in searching for new cognition enhancing drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900485-2

Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900485-2

Modified di- and tripeptides of the C-terminal portion of oxytocin and vasopressin as possible cognition activation agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900485-2

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900485-2

Inhibition of proliferative activity by cyclic dipeptides: spirocyclic derivatives of 1-aminocyclopentane-carboxylic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900485-2

10.1016/S0014-2999(96)00485-2

7 January 2021

Identifiers

DOI

1 reference

20 April 2018

1 reference

20 April 2018